Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).
Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome
Transplant-related mortality, Up to 12 months after the transplantation
Overall survival, Up to 12 months after the transplantation|Incidence of acute and chronic graft versus host disease, Up to 12 months after the transplantation|Progression-free survival, Up to 12 months after the transplantation|Severity of acute and chronic graft versus host disease, Up to 12 months after the transplantation|Relapse-related mortality, Up to 12 months after the transplantation
Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).